Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial
Authors
Robert Coleman,
Domenica LorussoAna Oaknin,
Sabrina Cecere,
Hannelore Denys,
Nicoletta Colombo,
Toon Gorp,
Jason Konner,
Margarita Romeo,
Philipp Harter,
Conleth Murphy,
Yuemei Wang,
Brooke Esteves,
Michael Method +12 authors
,
Ursula Matulonis Tip Tip